The Complications of Bariatric Surgery Patients with Type 2 Diabetes in the World: A Systematic Review and Meta-Analysis

Author(s): Ali Kabir*, Sara Mousavi, Abdolreza Pazouki*.

Journal Name: Current Diabetes Reviews

Volume 15 , Issue 1 , 2019

Submit Manuscript
Submit Proposal

Abstract:

Background: In this Meta-analysis, we aimed to quantify the incidence of complications of different methods of bariatric surgery on diabetic patients.

Introduction: Type 2 Diabetes Mellitus (T2DM) is increasing worldwide specifically in obese cases. Additionally, obesity worsens T2DM. Complications of each bariatric surgery method were assessed separately; but, a meta-analysis of these complications and comparison between procedures in T2DM patients have not been investigated previously. The result of this study will help surgeons to choose the most appropriate surgical technique, considering individual conditions for a diabetic patient.

Methods: We searched PubMed, Scopus, and ISI for original papers including bariatric surgical procedures for diabetic population and the reported consequences. Data analyses were done using Stata software.

Results: Mortality percentage between diabetic and non-diabetic patients was statistically nonsignificant (P = 0.987). Early and late complications were higher in diabetic group in comparison with non-diabetic (6.0% vs. 1.8%, P = 0.024 and 0.6% vs. 0.3%, P = 0.04, respectively). Most prevalent findings in malabsorptive (7.8%, P < 0.001) and restrictive procedures (80%, P < 0.001) were major complications and hypoglycemic episodes, respectively.

Conclusion: As our study showed, most of the complications are not necessarily higher in diabetic population but dependent on the method of surgery.

Keywords: Diabetes mellitus, Type 2, postoperative complications, methods of surgery, bariatric surgery, meta-analysis, systematic review.

[1]
International Diabetes Federation: In: IDF Diabetes Atlas. Brussels, Belgium 2013.
[2]
Hwang LC, Bai CH, Sun CA, et al. Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac J Clin Nutr 2012; 21(2): 227-33.
[3]
Van Gaal L, Scheen A. Weight management in type 2 diabetes: current and emerging approaches to treatment. Diabetes Care 2015; 38(6): 1161-72.
[4]
Gill RS, Sharma AM, Al-Adra DP, et al. The impact of bariatric surgery in patients with type-2 diabetes mellitus. Curr Diabetes Rev 2011; 7(3): 185-9.
[5]
Melissas J, Stavroulakis K, Tzikoulis V, et al. Sleeve gastrectomy vs. roux-en-y gastric bypass. Data from IFSO-European Chapter center of excellence program. Obes Surg 2017; 27(4): 847-55.
[6]
Kular KS, Manchanda N, Cheema GK. Seven years of mini-Gastric bypass in type ii diabetes patients with a body mass index <35 kg/m. Obes Surg 2016; 26(7): 1457-62.
[7]
Svane MS, Madsbad S. Bariatric surgery - effects on obesity and related co-morbidities. Curr Diabetes Rev 2014; 10(3): 208-14.
[8]
Kalyvas AV, Vlachos K, Abu-Amara M, et al. Bariatric surgery as metabolic surgery for diabetic patients. Curr Pharm Des 2014; 20(22): 3631-46.
[9]
] Abed O, Kabir A, Jesmi F, et al. Laparoscopic roux-en-y versus one anastomosis gastric bypass on remission of diabetes in morbid obesity. J Minim Invasive Surg Sci . 2017. e55991
[10]
Sundbom M. Laparoscopic revolution in bariatric surgery. World J Gastroenterol 2014; 20(41): 15135-43.
[11]
Chang S, Stoll CT, Song J, et al. The effectiveness and risks of bariatric surgery: An updated systematic review and meta-analysis, 2003-2012. JAMA Surg 2014; 149(3): 275-87.
[12]
Keidar A. Bariatric surgery for type 2 diabetes reversal: The risks. Diabetes Care 2011; 34(Suppl. 2): S361-266.
[13]
Lee WJ, Almulaifi A, Chong K, et al. Bariatric versus diabetes surgery after five years of follow up. Asian J Surg 2016; 39(2): 96-102.
[14]
Zorzela L, Loke YK, Ioannidis JP, et al. PRISMA harms checklist: improving harms reporting in systematic reviews. BMJ 2016; 352: i157.
[15]
Boza C, Munoz R, Salinas J, et al. Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients. Obes Surg 2011; 21(9): 1330-6.
[16]
Campos GM, Rabl C, Roll GR, et al. Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass vs. banding: Results of a 2-cohort pair-matched study. Arch Surg 2011; 146(2): 149-55.
[17]
Blackstone R, Kieran J, Davis M, et al. Continuous perioperative insulin infusion therapy for patients with type 2 diabetes undergoing bariatric surgery. Surg Endosc 2007; 21(8): 1316-22.
[18]
Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014; 311(22): 2297-304.
[19]
Savovic J, Weeks L, Sterne JA, et al. Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Syst Rev 2014; 3: 37.
[20]
Wells G, Shea B, O’connell D, et al. The Newcastle-Ottawa Scale(NOS) for assessing the quality of nonrandomised studies in metaanalyses, 2000.
[21]
Sarwar H, Chapman WH 3rd, Pender JR, et al. Hypoglycemia after Roux-en-Y gastric bypass: The BOLD experience. Obes Surg 2014; 24(7): 1120-4.
[22]
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366(17): 1567-76.
[23]
Kellogg TA, Bantle JP, Leslie DB, et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surgery for obesity and related diseases : Official journal of the American Society for Bariatric Surgery . 2008; 4(4): 492-9.
[24]
Marsk R, Jonas E, Rasmussen F, et al. Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden. Diabetologia 2010; 53(11): 2307-11.
[25]
Inabnet WB 3rd, Winegar DA, Sherif B, et al. Early outcomes of bariatric surgery in patients with metabolic syndrome: an analysis of the bariatric outcomes longitudinal database. J Am Coll Surg 2012; 214(4): 550-6.
[26]
Gupta PK, Franck C, Miller WJ, et al. Development and validation of a bariatric surgery morbidity risk calculator using the prospective, multicenter NSQIP dataset. J Am Coll Surg 2011; 212(3): 301-9.
[27]
Kim JH, Wolfe B. Bariatric/metabolic surgery: short- and longterm safety. Curr Atheroscler Rep 2012; 14(6): 597-605.
[28]
Chuah LL, Papamargaritis D, Pillai D, et al. Morbidity and mortality of diabetes with surgery. Nutr Hosp 2013; 28(Suppl. 2): 47-52.
[29]
Bradley JF 3rd, Ross SW, Christmas AB, et al. Complications of bariatric surgery: The acute care surgeon’s experience. Am J Surg 2015; 210(3): 456-61.
[30]
Weiner RA, El-Sayes IA, Theodoridou S, et al. Early postoperative complications: Incidence, management, and impact on length of hospital stay. A retrospective comparison between laparoscopic gastric bypass and sleeve gastrectomy. Obes Surg 2013; 23(12): 2004-12.
[31]
Nguyen NT, Masoomi H, Laugenour K, et al. Predictive factors of mortality in bariatric surgery: Data from the Nationwide Inpatient Sample. Surgery 2011; 150(2): 347-51.
[32]
Dorman RB, Miller CJ, Leslie DB, et al. Risk for hospital readmission following bariatric surgery. PLoS One 2012; 7(3): e32506.
[33]
Halperin F, Goldfine AB. Metabolic surgery for type 2 diabetes: efficacy and risks. Curr Opin Endocrinol Diabetes Obes 2013; 20(2): 98-105.
[34]
Chivot C, Robert B, Lafaye N, et al. Laparoscopic sleeve gastrectomy: Imaging of normal anatomic features and postoperative gastrointestinal complications. Diagn Interv Imaging 2013; 94(9): 823-34.
[35]
Corcelles R, Daigle CR, Schauer PR. Management Of Endocrine Disease: Metabolic effects of bariatric surgery. European journal of endocrinology / European Federation of Endocrine Societies 2016; 174(1): R19-28.
[36]
Golder S, Loke YK. Reporting of adverse events in published and unpublished studies of health care interventions: A systematic review. PLoS Med 2016; 13(9): e1002127.
[37]
Kaska L, Proczko M, Kobiela J, et al. Dynamics of type 2 diabetes mellitus laboratory remission after Roux-en-Y gastric bypass in patients with body mass index lower than 35 kg/m(2) and higher than 35 kg/m(2) in a 3-year observation period. Wideochir Inne Tech Malo Inwazyjne 2014; 9(4): 523-30.


Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 15
ISSUE: 1
Year: 2019
Page: [49 - 61]
Pages: 13
DOI: 10.2174/1573399814666180403164529
Price: $58

Article Metrics

PDF: 23
HTML: 6
PRC: 1